The Journey to a Cure for Hepatitis C

Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug Sovaldi, discusses the research that led to the discovery of the groundbreaking HCV treatment.
PUBLISHED MONDAY, FEBRUARY 1, 2016
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug Sovaldi, discusses the research that led to the discovery of the groundbreaking HCV treatment.



 
Recommended Articles
Study finds a common assortment of reasons for non-initiation of HCV therapy, regardless of patient race or ethnicity.
Managing the risk of hepatitis C and liver disease among infants born to mothers with chronic HCV is a challenge.
HCV patients with cirrhosis and severe sepsis face elevated risk of organ failure.
Anti-retroviral drug therapy may effectively treat hepatitis C-HIV coinfection.
$auto_registration$